Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (321-330 of 621) with videos related to

Pageof 63
Sort By:
Arthritis and Rheumatism|December 1, 2007
Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosisJörg H W Distler, Astrid Jüngel, Margarita Pileckyte, et al.
Clinical Rheumatology|December 27, 2022
HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management RegistryFabienne Fröhlich, Raphael Micheroli, Monika Hebeisen, et al.
Arthritis and Rheumatism|February 12, 2011
Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosisClara Dees, Pawel Zerr, Michal Tomcik, et al.
Frontiers in Immunology|June 4, 2019
OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic SclerosisMiki Takata, Elena Pachera, Mojca Frank-Bertoncelj, et al.
Annals of the Rheumatic Diseases|January 10, 2018
Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulatorsAlexandru-Emil Matei, Christian Beyer, Andrea-Hermina Györfi, et al.
Annals of the Rheumatic Diseases|May 8, 2017
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatmentYun Zhang, Ruifang Liang, Chih-Wei Chen, et al.
The Journal of Clinical Investigation|January 29, 2020
TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosisClara Dees, Sebastian Pötter, Yun Zhang, et al.
Arthritis Research & Therapy|October 26, 2018
Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre studyUlrich A Walker, Veronika K Jaeger, Katharina M Bruppacher, et al.
Rheumatology (Oxford, England)|January 23, 2023
Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosisNoemi Strahm, Henriette Didriksen, Håvard Fretheim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 6, 2014
Cardiomyopathy in murine models of systemic sclerosisPaulius Venalis, Gábor Kumánovics, Hendrik Schulze-Koops, et al.
Pageof 63

Showing results (321-330 of 621) with videos related to

Sort By:
Pageof 63
Arthritis and Rheumatism|December 1, 2007
Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosisJörg H W Distler, Astrid Jüngel, Margarita Pileckyte, et al.
Clinical Rheumatology|December 27, 2022
HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management RegistryFabienne Fröhlich, Raphael Micheroli, Monika Hebeisen, et al.
Arthritis and Rheumatism|February 12, 2011
Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosisClara Dees, Pawel Zerr, Michal Tomcik, et al.
Frontiers in Immunology|June 4, 2019
OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic SclerosisMiki Takata, Elena Pachera, Mojca Frank-Bertoncelj, et al.
Annals of the Rheumatic Diseases|January 10, 2018
Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulatorsAlexandru-Emil Matei, Christian Beyer, Andrea-Hermina Györfi, et al.
Annals of the Rheumatic Diseases|May 8, 2017
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatmentYun Zhang, Ruifang Liang, Chih-Wei Chen, et al.
The Journal of Clinical Investigation|January 29, 2020
TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosisClara Dees, Sebastian Pötter, Yun Zhang, et al.
Arthritis Research & Therapy|October 26, 2018
Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre studyUlrich A Walker, Veronika K Jaeger, Katharina M Bruppacher, et al.
Rheumatology (Oxford, England)|January 23, 2023
Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosisNoemi Strahm, Henriette Didriksen, Håvard Fretheim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 6, 2014
Cardiomyopathy in murine models of systemic sclerosisPaulius Venalis, Gábor Kumánovics, Hendrik Schulze-Koops, et al.
Pageof 63